Admedus Limited announced US FDA clearance of an indication change to its ADAPT®-treated (bovine pericardium) tissue through the Special 510(k) pathway. The change extends ADAPT® tissue approval for use in cardiac defects, including intracardiac defects, septal defects and valve and annulus repairs.